Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lucid Diagnostics (LUCD) Total Liabilities (2020 - 2026)

Lucid Diagnostics filings provide 6 years of Total Liabilities readings, the most recent being $29.5 million for Q4 2025.

  • On a quarterly basis, Total Liabilities rose 16.53% to $29.5 million in Q4 2025 year-over-year; TTM through Dec 2025 was $29.5 million, a 16.53% increase, with the full-year FY2025 number at $29.5 million, up 16.53% from a year prior.
  • Total Liabilities hit $29.5 million in Q4 2025 for Lucid Diagnostics, up from $27.4 million in the prior quarter.
  • In the past five years, Total Liabilities ranged from a high of $38.2 million in Q1 2025 to a low of $4.3 million in Q4 2021.
  • Median Total Liabilities over the past 5 years was $22.2 million (2023), compared with a mean of $21.5 million.
  • Biggest five-year swings in Total Liabilities: tumbled 72.89% in 2021 and later soared 212.63% in 2023.
  • Lucid Diagnostics' Total Liabilities stood at $4.3 million in 2021, then surged by 122.11% to $9.5 million in 2022, then soared by 212.63% to $29.6 million in 2023, then fell by 14.39% to $25.3 million in 2024, then rose by 16.53% to $29.5 million in 2025.
  • The last three reported values for Total Liabilities were $29.5 million (Q4 2025), $27.4 million (Q3 2025), and $30.8 million (Q2 2025) per Business Quant data.